Parallel Industries Inc. (EAPH)
Parallel Industries Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $26,899. On trailing twelve-month figures it carries a trailing P/E of -0.20, a net margin of 0.0%. Its beta of -8.88 implies it has historically moved less than the broad market.
Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.
Parallel Industries Inc. is most often compared with the following Healthcare names: